ArticleFrontiers in oncology2026

Case Report: Neuroretinitis following combination checkpoint inhibition therapy with nivolumab and ipilimumab for stage IIIC melanoma.

Nuha S Arefin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.